Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 265.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 265.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\22798295
.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 Mol+Endocrinol
2012 ; 26
(9
): 1603-16
Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Identification of common and distinctive mechanisms of resistance to different
anti-IGF-IR agents in Ewing s sarcoma
#MMPMID22798295
Garofalo C
; Mancarella C
; Grilli A
; Manara MC
; Astolfi A
; Marino MT
; Conte A
; Sigismund S
; Carč A
; Belfiore A
; Picci P
; Scotlandi K
Mol Endocrinol
2012[Sep]; 26
(9
): 1603-16
PMID22798295
show ga
IGF system contributes significantly to many human malignancies. Targeting IGF-I
receptor (IGF-IR) has been reported to be active against several tumors, but
particular efficacy was observed only against a minority of Ewing's sarcoma
patients. Identification of mechanisms of acquired resistance to anti-IGF-IR
agents is mandatory to individualize their use in clinics and optimize cure
costs. In this study, we compared gene expression profiles of cells made
resistant with three different anti-IGF-IR drugs (human antibodies AVE1642,
Figitumumab, or tyrosine kinase inhibitor NVP-AEW541) to highlight common and
distinctive mechanisms of resistance. Among common mechanisms, we identified two
molecular signatures that distinguish sensitive from resistant cells. Annotation
analysis indicated some common altered pathways, such as insulin signaling, MAPK
pathway, endocytosis, and modulation of some members of the interferon-induced
transmembrane protein family. Among distinctive pathways/processes, resistance to
human antibodies involves mainly genes regulating neural differentiation and
angiogenesis, whereas resistance to NVP-AEW541 is mainly associated with
alterations in genes concerning inflammation and antigen presentation. Evaluation
of the common altered pathways indicated that resistant cells seem to maintain
intact the IGF-IR internalization/degradation route of sensitive cells but
constantly down-regulated its expression. In resistant cells, the loss of
proliferative stimulus, normally sustained by IGF-I/IGF-IR autocrine loop in
Ewing's sarcoma cells, is compensated by transcriptional up-regulation of IGF-II
and insulin receptor-A; this signaling seems to favor the MAPK pathway over the
v-akt murine thymoma viral oncogene homolog 1 pathway. Overall, complexity of IGF
system requires analytical evaluation of its components to select those patients
that may really benefit from this targeted therapy and support the idea of
cotargeting IGF-IR and insulin receptor-A to increase the efficacy.